ArticlePloS one2014

Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.

Elizabeth Harford-Wright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.